As we enter the third week of the new year, the natural diamond market continues to demonstrate encouraging signs of stability, strength and growth. Most jewelers reported a solid year-end performance, with sales levels holding steady or improving compared to last year. This positive momentum reinforces the resilience of natural diamonds as symbols of cherished […]
Guidewire Software Inc. (NYSE: GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead Pharmaceuticals will replace Barnes Group Inc. (NYSE: B) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, January 27. S&P 500 constituent Apollo Global Management Inc. (NYSE: APO) is acquiring Barnes
— Revenues for 2024 at 66.1930 trillion won, operating profit at 23.4673 trillion won, net profit at 19.7969 trillion won — Revenues for Q4 at 19.7670 trillion won, operating profit at 8.0828 trillion won, net profit at 8.0065 trillion won — Achieving best-ever quarterly and yearly performance with increased sales of AI memory products including
Platte Woods, MO – Roof Works, a leading roofing contractor located in Platte Woods, MO, is proud to provide a full range of roofing services to the Platte Woods community and surrounding areas. With a commitment to excellence, the roofing contractor specializes in residential and commercial roofing solutions designed to meet the unique needs of
In the news release, Starbird Celebrates Record-Breaking 2024 with Expansion, Innovation and Community Impact, issued 21-Jan-2025 by Starbird Chicken over PR Newswire, we are advised by the company that the second, third and fourth paragraphs have been updated.The complete, corrected release follows: Starbird Celebrates Record-Breaking 2024 with Expansion, Innovation and Community Impact Super-Premium Fast-Food Concept
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Block, Inc. (NYSE:SQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/block-inc-lawsuit-submission-form-2?prid=124484&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ:SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline in the securities
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Match Group, Inc. (NASDAQ:MTCH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/match-group-inc-lawsuit-submission-form?prid=124475&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Polestar Automotive Holding UK PLC ("Polestar" or the "Company") (NASDAQ:PSNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Polestar and certain of its officers
Several leading classes of therapies are exploring diverse mechanisms of action to treat CHF, including SGLT2 inhibitors, cardiac myosin activators, myeloperoxidase inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, cell therapies, and more. This growing focus is expected to drive the chronic heart failure market forward. In summary, the existing blockbuster therapies such as Entresto, recently